Gam Holding Ag Voyager Therapeutics, Inc. Transaction History

Gam Holding Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$17.11 - $21.74 $513,300 - $652,200	-30,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$16.16 - $31.31 $297,344 - $576,104	-18,400 Reduced 38.02%	30,000 $564,000
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $593,384 - $1.25 Million	48,400	48,400 $803,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $219M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.